Last mentioned: Mar 17, 2026
Regulatory Implementation
Effective date for the first wave of state-level ADAP regulatory changes and income threshold adjustments.
State Announcements
Multiple states officially announce new eligibility restrictions and the implementation of waitlist protocols.
Federal Guidance
HRSA issues guidance on state flexibility for utilizing Ryan White Part B funds amid rising drug costs.
Budget Proposals
Initial state budget drafts suggest significant shortfalls in ADAP funding for the 2026 fiscal year.
Multiple states have begun implementing restrictive eligibility requirements for HIV Drug Assistance Programs (ADAPs) due to budgetary constraints. These regulatory changes are expected to increase compliance burdens for healthcare providers and reshape pharmaceutical procurement strategies.